In terms of AstraZeneca, I’ve spoken with the chair of CSL, Brian McNamee, today, and have been engaging with Liz Chapman, who’s the Australian CEO of AstraZeneca – both have confirmed that CSL and AstraZeneca are on track to complete the full 50 million-dose production run in Australia and the 3.8 million supply from overseas.
So, 53.8 million AstraZeneca doses. So, our expectation and our plan is that that program will be completed in full.
And all of those extra doses are being supplied to the region. So, Fiji has very much built its vaccination program with the support of Australian AstraZeneca. It’s made a huge difference there.
There’s a very significant offer – DFAT is coordinating it right across the region. PNG, as you mentioned, our Pacific Forum friends and neighbours, Indonesia, Vietnam we have been able to support, and others.
So, all of these items are coming together and we’ll continue to support them both directly with our AstraZeneca, which I’m really pleased to be able to say – the confirmation I’ve had today – on track, delivery in full.